June 12, 2018

ASCO 2018: PET imaging may top CT in predicting therapy response in melanoma patients

PET imaging may better predict long-term benefits and guide discontinuation of therapy compared to standard contrast CT for patients with metastatic melanoma, according to findings presented Monday, June 4, at the 2018 American Society of Clinical Oncology (ASCo) annual meeting in Chicago. {read more here}